Article 25 Apr 2024 Fresenius Kabi Announces Launch Of TYENNE, A Tocilizumab Biosimilar Referencing ACTEMRA United States Healthcare
Article 19 Mar 2024 Fresenius Kabi Announces FDA Approval Of TYENNE, A Tocilizumab Biosimilar Referencing ACTEMRA United States Healthcare
Article 11 Jan 2024 Regeneron's Disputes With Celltrion, Samsung Bioepis, And Formcycon On Service And Personal Jurisdiction In Aflibercept BPCIA Litigation United States IP
Article 31 Oct 2023 Celltrion Announces FDA Approval Of ZYMFENTRA (Infliximab-dyyb) United States Healthcare
Article 27 Oct 2023 Genentech And Biogen File Joint Stipulation Of Dismissal In BPCIA Litigation Regarding Tocilizumab United States Healthcare
Article 17 Aug 2023 FDA Issues Draft Guidance On Formal Meetings Between The FDA And Sponsors Or Applicants Of BsUFA Products And Classification Categories For Certain Supplements Under BsUFA III United States Healthcare
Article 24 Jan 2023 Genentech And Tanvex Reach Settlement In Principle In Trastuzumab BPCIA Litigation United States IP